ALSO NOTED: Genetic test for warfarin sensitivity OK'd; Bayer boosts OTC production

> The FDA also cleared a new genetic test to determine over-sensitivity to the blood thinner warfarin, a month after updating drug labeling to alert doctors that patients carrying certain genes respond differently. Release

> Bayer is ramping up its production of OTC drugs at its Bitterfield, Germany, manufacturing plant, aiming to boost output to 6 million pills this year, up from 4.1 million in 2006. Report

And Finally... We're used to news that antibiotics can spawn resistant superbugs. But a vaccine? Apparently, Wyeth's super-successful Prevnar shot has successfully prevented pneumonia, meningitis, and other infections, but it's also cleared the way for a new, resistant strain of strep. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.